Conference
Use of changes in serum alkaline phosphatase to predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy: A retrospective analysis of the TAX327 trial.
Authors
Pond GR; Sonpavde G; Berry WR; De Wit R; Armstrong AJ; Eisenberger MA; Tannock I
Volume
28
Pagination
pp. 4637-4637
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2010
DOI
10.1200/jco.2010.28.15_suppl.4637
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X